|4Jan 31, 7:48 AM ET

Nolan Lisa 4

4 · REXAHN PHARMACEUTICALS, INC. · Filed Jan 31, 2019

Insider Transaction Report

Form 4
Period: 2019-01-30
Nolan Lisa
Chief Business Officer
Transactions
  • Purchase

    Common Stock

    2019-01-30$0.65/sh+20,000$12,96021,625 total
Footnotes (1)
  • [F1]The price of $0.648 per share represents a weighted average of purchase prices ranging from $0.635 to $0.650 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4